Dr. Jeremy D. Schmahmann, MD

Dr. Schmahmann practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Schmahmann's NPI, 1306810015, was assigned on February 17, 2006. Dr. Schmahmann holds Massachusetts license 54683.

Dr. Schmahmann's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Schmahmann's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Schmahmann is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Schmahmann to 5 more hospitals, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schmahmann practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Schmahmann's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Schmahmann is licensed in Massachusetts.

CMS data shows 460 Medicare services from Dr. Schmahmann across 3 procedure codes in 2024, for 159 Medicare patients. Medicare paid $33,382 for them. Every service was in an office.

CMS counts 159 Medicare patients who saw Dr. Schmahmann in 2024. The largest group is 75 to 84, with 63 patients. 71% of them have high cholesterol, and 59% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schmahmann's median patient age at 66, with 52% women.

In 2024, Dr. Schmahmann wrote 875 Medicare Part D claims for 126 patients. 95% of them were for generic drugs. CMS names the drug for 706 of them, across 21 drugs with 11 or more claims each, at $1,025,928 in total drug cost. In 2023, CMS named 644 claims across 22 drugs.

Dr. Schmahmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schmahmann as offering telehealth.

Dmand AI links 152 papers to Dr. Schmahmann, published from 2004 to 2025. 2025 was the busiest year, with 15. The most frequent topics are Cerebellum, Magnetic Resonance Imaging and Cerebellar Ataxia. Dr. Schmahmann has published most often in Cerebellum. Dr. Schmahmann's most frequent co-authors are Christopher David Stephen, MD, Anoopum Satyawan Gupta, MD, PhD and Christopher M. Gomez.

Dmand AI links Dr. Schmahmann to 2 clinical trials. Conditions studied include Machado-Joseph Disease and Spinocerebellar Ataxias.

CMS Open Payments shows 12 general payments to Dr. Schmahmann from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 53% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $13,509. It also lists 1 research payment totaling $4,661 in 2021.